PANAGORA ASSET MANAGEMENT INC

Position in BBIO — BridgeBio Pharma, Inc.

CIK 883677 Boston, MA

Position in BBIO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$55,109,608

-$1,404,493 QoQ

Shares Held

742,117

+0.4% QoQ

Ownership

0.379%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 13% Shared 0% None 87%

Healthcare · as of Mar 31, 2026

PANAGORA ASSET MANAGEMENT INC holds $504,243,073 across 65 Biotechnology names. BBIO ranks #3 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,210,909	$113,970,755
2	REGN	Regeneron Pharmaceuticals, Inc.	105,225	$81,301,044
3	BBIO	BridgeBio Pharma, Inc. This page	742,117	$55,109,608
4	ARWR	Arrowhead Pharmaceuticals, Inc.	461,193	$28,916,801
5	JAZZ	Jazz Pharmaceuticals plc	143,499	$27,128,485
6	PTCT	Ptc Therapeutics, Inc.	351,370	$23,938,838
7	TVTX	Travere Therapeutics, Inc.	592,912	$17,615,415
8	ONC	BeOne Medicines Ltd.	57,320	$17,022,320

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$55,109,608	742,117	+0.4%	Shares	Sole	2026-05-14
2025-12-31	$56,514,101	738,843	+1.3%	Shares	Sole	2026-02-13
2025-09-30	$37,891,476	729,524	+2.2%	Shares	Sole	2025-11-13
2025-06-30	$30,808,541	713,491	+15.8%	Shares	Sole	2025-08-13
2025-03-31	$21,303,831	616,252	+21.1%	Shares	Sole	2025-05-15
2024-12-31	$13,961,664	508,807	-32.1%	Shares	Sole	2025-02-13
2024-09-30	$19,064,931	748,819	+2.9%	Shares	Sole	2024-11-13
2024-06-30	$18,439,302	727,963	+75.3%	Shares	Sole	2024-07-29
2024-03-31	$12,840,364	415,277	+115.3%	Shares	Sole	2024-05-07
2023-12-31	$7,785,031	192,842	+9.2%	Shares	Sole	2024-02-08
2023-09-30	$4,655,465	176,544	+25.9%	Shares	Sole	2023-10-31
2023-06-30	$2,412,214	140,245	+3354.3%	Shares	Sole	2023-08-11
2021-06-30	$247,497	4,060	—	Shares	Sole	2021-08-11
No filing history on record for this holder in this stock.